Specialists are on the cusp of launching the primary new male prophylactic in over a century. But instead than a Big Pharma lab, the leap forward is emerging from a college startup in the core of country India.
A long time of human trials on the injectable,
Comments
Content
Specialists are on the cusp of launching the primary new male prophylactic in over a century. But instead than a Big Pharma lab, the leap forward is emerging from a college startup in the core of country India.
A long time of human trials on the injectable,